Moderna Analyst Ratings
Moderna Analyst Ratings
Redburn Atlantic Adjusts Moderna's Price Target to $73 From $102, Keeps Neutral Rating
Goldman Sachs Adjusts Price Target on Moderna to $130 From $139
Gritstone Downgraded by Jones, B. Riley Over Cancer Vaccine Data
Evercore ISI Adjusts Price Target on Moderna to $120 From $105, Maintains In Line
Deutsche Bank Cuts Moderna Price Target to $75 From $80
Moderna Analyst Ratings
RBC Capital Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $75
Goldman Sachs Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $139
Morgan Stanley Maintains Moderna(MRNA.US) With Hold Rating, Maintains Target Price $70
Barclays Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $125
Morgan Stanley Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $70
Brookline Capital Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $238
Moderna Continues to Decline as Oppenheimer Latest to Downgrade
Moderna Is Maintained at Hold by TD Cowen
BofA Securities Maintains Moderna(MRNA.US) With Hold Rating, Maintains Target Price $110
Moderna Cut to Underweight From Neutral by JP Morgan
Jefferies Downgrades Moderna to Hold, Lowers Price Target to $65
A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $94 to $125